Evidence map›Paper›PMID 39021875›Full record

ArticleJournal of pregnancy2024

Medication Use Among Pregnant Women With SARS-CoV-2 Infection and Risk of Hospitalization-A Study in Two Brazilian Hospitals.

Ricardo Rohweder, Natálya G Pereira, Bruna H Micheletti, Jéssica Mosello, Júlia R M Campos, Matheus G Pereira, Cristina N Santos, Natália L Simões, Regina L B Matielo, Lisandra S Bernardes and 5 more

Abstract readMulticenter Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of pregnancy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Ricardo RohwederGraduate Program in Genetics and Molecular Biology Department of Genetics Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.ORCID https://orcid.org/0000-0001-5297-5916
Natálya G PereiraDepartment of Obstetrics and Neonatology Hospital e Maternidade SEPACO, São Paulo, Brazil.ORCID https://orcid.org/0000-0003-0894-8093
Bruna H MichelettiDepartment of Obstetrics and Neonatology Hospital e Maternidade SEPACO, São Paulo, Brazil.ORCID https://orcid.org/0009-0004-3057-0714
Jéssica MoselloDepartment of Obstetrics and Neonatology Hospital e Maternidade SEPACO, São Paulo, Brazil.ORCID https://orcid.org/0009-0002-0283-436X
Júlia R M CamposDepartment of Obstetrics and Neonatology Hospital e Maternidade SEPACO, São Paulo, Brazil.ORCID https://orcid.org/0009-0005-2755-2344
Matheus G PereiraDepartment of Obstetrics and Neonatology Hospital e Maternidade SEPACO, São Paulo, Brazil.ORCID https://orcid.org/0009-0003-1645-8833
Cristina N SantosDepartment of Obstetrics and Neonatology Hospital e Maternidade SEPACO, São Paulo, Brazil.ORCID https://orcid.org/0000-0001-7710-7461
Natália L SimõesDepartment of Obstetrics and Neonatology Hospital e Maternidade SEPACO, São Paulo, Brazil.ORCID https://orcid.org/0009-0006-3885-7140
Regina L B MatieloDepartment of Obstetrics and Neonatology Hospital e Maternidade SEPACO, São Paulo, Brazil.ORCID https://orcid.org/0009-0009-6995-624X
Lisandra S BernardesDepartment of Obstetrics and Neonatology Hospital e Maternidade SEPACO, São Paulo, Brazil.ORCID https://orcid.org/0000-0003-2367-2849
Maria L R OppermannGynecology and Obstetrics Service Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil.ORCID https://orcid.org/0000-0002-6578-995X
Maria C O WenderGynecology and Obstetrics Service Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil.ORCID https://orcid.org/0000-0001-9085-4605
Angela LupattelliPharmacoEpidemiology and Drug Safety Research Group Department of Pharmacy University of Oslo, Oslo, Norway.ORCID https://orcid.org/0000-0002-8787-3183
Hedvig NordengPharmacoEpidemiology and Drug Safety Research Group Department of Pharmacy University of Oslo, Oslo, Norway.ORCID https://orcid.org/0000-0001-6361-2918
Lavinia Schuler-FacciniGraduate Program in Genetics and Molecular Biology Department of Genetics Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.ORCID https://orcid.org/0000-0002-2428-0460

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There is limited evidence about the use of medications among pregnant women with COVID-19, as well as risk factors for hospitalization due to COVID-19 in pregnancy. We aimed to describe the use of medications among SARS-CoV-2-positive pregnant women at the time around infection and identify predictors for hospitalization due to COVID-19 in two hospitals in Brazil. This is a hospital record-based study among pregnant women with positive SARS-CoV-2 tests between March 2020 and August 2022 from two Brazilian hospitals. Characteristics of sociodemographic, obstetrical, and COVID-19 symptoms were extracted retrospectively. The prevalence use of medications was based on self-reported use, and this was administered at the hospital. Logistic regression was used to estimate predictors of hospitalization due to COVID-19. There were 278 pregnant women included in the study, of which 41 (14.7%) required hospitalization due to COVID-19. The remaining 237 (85.3%) had mild symptoms or were asymptomatic. Most of the women had the infection in the third trimester (

Indexed as

COVID-19HospitalizationPregnancy Complications, InfectiousSARS-CoV-2AdultAnti-Bacterial AgentsBrazilCOVID-19 Drug TreatmentFemaleHumansPregnancyRetrospective StudiesRisk FactorsYoung AdultAnti-Bacterial Agents

Identifiers

PMID39021875
PMCPMC11254464

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.